Medigene AG (WBO:MDG1) FCF Yield % : -40.54 (As of Apr. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medigene AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Medigene AG's Trailing 12-Month Free Cash Flow is €-15.78 Mil, and Market Cap is €38.93 Mil. Therefore, Medigene AG's FCF Yield % for today is -40.54%.

The historical rank and industry rank for Medigene AG's FCF Yield % or its related term are showing as below:

WBO:MDG1' s FCF Yield % Range Over the Past 10 Years
Min: -44.78 Med: -11.76 Max: 31.34
Current: -40.54

During the past 13 years, the highest FCF Yield % of Medigene AG was 31.34%. The lowest was -44.78%. And the median was -11.76%.

WBO:MDG1's FCF Yield % is ranked worse than
71.14% of 1549 companies
in the Biotechnology industry
Industry Median: -15.5 vs WBO:MDG1: -40.54

Medigene AG's FCF Margin % for the quarter that ended in Dec. 2023 was -245.93%.

Medigene AG FCF Yield % Historical Data

The historical data trend for Medigene AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG FCF Yield % Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-18.16

-29.09

-15.66

21.63

-41.29

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-9.93	60.32	-24.07	-35.86	-38.22

Competitive Comparison of Medigene AG's FCF Yield %

For the Biotechnology subindustry, Medigene AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Medigene AG's FCF Yield % falls into.

Medigene AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Medigene AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-15.783	/	38.22425748
	=	-41.29%

Medigene AG's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-7.304	*	2	/	38.22425748
	=	-38.22%

Medigene AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Medigene AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Medigene AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (WBO:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines